• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物依赖男性和女性中阿片类药物替代疗法使用情况的比较研究。

A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.

作者信息

Gisev Natasa, Degenhardt Louisa, Larney Sarah, Larance Briony, Gibson Amy, Kimber Jo, Burns Lucy

机构信息

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.

出版信息

Drug Alcohol Rev. 2014 Sep;33(5):499-505. doi: 10.1111/dar.12151. Epub 2014 May 20.

DOI:10.1111/dar.12151
PMID:24840554
Abstract

INTRODUCTION AND AIMS

Few population-based studies have examined differences in opioid substitution therapy (OST) treatment utilisation between men and women. Using a population of opioid-dependent people in New South Wales, Australia, first-episode and long-term OST treatment utilisation profiles were compared between men and women, differentiating between treatment initiation in the community and in custody.

DESIGN AND METHODS

Retrospective data linkage study using records of new OST entrants (2001-2010) and custody episodes (2000-2012). First OST treatment episode and overall treatment utilisation characteristics were compared between men and women initiating treatment in the community or in custody. Treatment retention was evaluated at 3, 6, 9 and 12 months after first commencing OST and overall, as the median proportion of follow-up time spent in treatment.

RESULTS

There were 15,600 new OST entrants in the cohort--10,930 were men (70.1%) and 4670 women (29.9%); 12,584 (80.7%) initiated treatment in the community and 3016 (19.3%) in custody. More men initiated OST in custody (24.0% vs. 8.3%, P < 0.001) and only received OST in custody (57.5% vs. 41.8%, P < 0.001). Women were retained longer in their first OST treatment episode at all four time points in both treatment settings and in treatment overall (community: 46.6% vs. 39.1%, P < 0.001; custody: 41.3% vs. 30.8%, P < 0.001).

DISCUSSION AND CONCLUSIONS

There are a number of key differences in OST treatment utilisation profiles between men and women. Whereas men commonly initiate and only receive OST in custody, treatment retention is higher among women, independent of the setting treatment is initiated.

摘要

引言与目的

很少有基于人群的研究探讨过男女在阿片类药物替代疗法(OST)治疗利用方面的差异。利用澳大利亚新南威尔士州阿片类药物依赖人群,比较了男性和女性首次发作及长期OST治疗利用情况,区分了在社区和羁押场所开始治疗的情况。

设计与方法

采用回顾性数据关联研究,利用新OST入组者(2001 - 2010年)和羁押事件(2000 - 2012年)的记录。比较了在社区或羁押场所开始治疗的男性和女性的首次OST治疗发作及总体治疗利用特征。在首次开始OST治疗后的3、6、9和12个月以及总体上,将治疗保留率评估为随访时间中接受治疗的中位比例。

结果

该队列中有15600名新的OST入组者,其中男性10930名(70.1%),女性4670名(29.9%);12584名(80.7%)在社区开始治疗,3016名(19.3%)在羁押场所开始治疗。更多男性在羁押场所开始OST治疗(24.0%对8.3%,P < 0.001)且仅在羁押场所接受OST治疗(57.5%对41.8%,P < 0.001)。在两种治疗环境下的所有四个时间点以及总体治疗中,女性在首次OST治疗发作中的保留时间更长(社区:46.6%对39.1%,P < 0.001;羁押场所:41.3%对30.8%,P < 0.001)。

讨论与结论

男女在OST治疗利用情况方面存在一些关键差异。男性通常在羁押场所开始并仅在羁押场所接受OST治疗,而女性的治疗保留率更高,与开始治疗的环境无关。

相似文献

1
A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.阿片类药物依赖男性和女性中阿片类药物替代疗法使用情况的比较研究。
Drug Alcohol Rev. 2014 Sep;33(5):499-505. doi: 10.1111/dar.12151. Epub 2014 May 20.
2
Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians.与刑事司法系统有接触的阿片类药物依赖者的犯罪、拘留及阿片类药物替代疗法治疗利用情况:澳大利亚原住民与非原住民的比较
BMC Public Health. 2014 Sep 6;14:920. doi: 10.1186/1471-2458-14-920.
3
A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.澳大利亚新南威尔士州美沙酮和丁丙诺啡维持治疗阿片类药物依赖的纵向比较。
Addiction. 2015 Apr;110(4):646-55. doi: 10.1111/add.12834.
4
A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.澳大利亚新南威尔士州监狱中寻求和停止阿片类药物替代治疗的原因的定性研究。
Drug Alcohol Rev. 2017 May;36(3):305-310. doi: 10.1111/dar.12442. Epub 2016 Jun 21.
5
The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.出狱后阿片类药物替代疗法对死亡率的影响:回顾性数据链接研究。
Addiction. 2014 Aug;109(8):1306-17. doi: 10.1111/add.12536. Epub 2014 Apr 14.
6
A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.阿片类药物替代疗法对刑满释放人员降低阿片类药物依赖史者死亡率的成本效益分析。
Addiction. 2015 Dec;110(12):1975-84. doi: 10.1111/add.13073. Epub 2015 Sep 23.
7
Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.监狱内阿片类药物替代治疗和释放后治疗保留对再监禁风险的影响。
Addiction. 2012 Feb;107(2):372-80. doi: 10.1111/j.1360-0443.2011.03618.x. Epub 2011 Oct 26.
8
Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007-2013.2007 - 2013年,在向临床治理安排转变期间对一个监狱阿片类药物治疗项目进行监测
J Subst Abuse Treat. 2016 Nov;70:58-63. doi: 10.1016/j.jsat.2016.08.001. Epub 2016 Aug 10.
9
Retention in Georgia opioid substitution therapy program and associated factors.佐治亚州阿片类药物替代疗法项目的留存率及相关因素。
Harm Reduct J. 2016 Dec 8;13(1):35. doi: 10.1186/s12954-016-0124-z.
10
Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.审前羁押中的阿片类药物替代治疗:来自瑞士日内瓦的案例研究。
Swiss Med Wkly. 2013 Nov 1;143:w13898. doi: 10.4414/smw.2013.13898. eCollection 2013.

引用本文的文献

1
Structural violence and the need for compassionate use of methadone in Mexico.结构性暴力与在墨西哥对美沙酮进行同情性使用的必要性。
BMC Public Health. 2022 Mar 29;22(1):606. doi: 10.1186/s12889-022-12955-x.
2
Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions.从全球视角看注射吸毒妇女和女孩群体中作为艾滋病预防手段的药物治疗:进展、差距与未来方向
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2(0 1):S155-61. doi: 10.1097/QAI.0000000000000637.